These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 3024991)
1. Emetic and antiemetic effects of opioids in the dog. Blancquaert JP; Lefebvre RA; Willems JL Eur J Pharmacol; 1986 Sep; 128(3):143-50. PubMed ID: 3024991 [TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity. Picker MJ; Cook CD Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011 [TBL] [Abstract][Full Text] [Related]
3. Enkephalin receptors in the emetic chemoreceptor trigger zone of the dog. Bhargava KP; Dixit KS; Gupta YK Br J Pharmacol; 1981 Mar; 72(3):471-5. PubMed ID: 6266566 [TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists. Picker MJ; Dykstra LA J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680 [TBL] [Abstract][Full Text] [Related]
5. The actions of fentanyl to inhibit drug-induced emesis. Barnes NM; Bunce KT; Naylor RJ; Rudd JA Neuropharmacology; 1991 Oct; 30(10):1073-83. PubMed ID: 1661861 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074 [TBL] [Abstract][Full Text] [Related]
7. Antiaversive properties of opioids in the conditioned taste aversion test in the rat. Blancquaert JP; Lefebvre RA; Willems JL Pharmacol Biochem Behav; 1987 Jul; 27(3):437-41. PubMed ID: 2821551 [TBL] [Abstract][Full Text] [Related]
8. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine. Foss JF; Yuan CS; Roizen MF; Goldberg LI Cancer Chemother Pharmacol; 1998; 42(4):287-91. PubMed ID: 9744773 [TBL] [Abstract][Full Text] [Related]
9. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ; Takemori AE J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119 [TBL] [Abstract][Full Text] [Related]
10. Further study of kappa opioids on increased urination. Leander JD J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557 [TBL] [Abstract][Full Text] [Related]
11. Place-conditioning properties of mu, kappa, and sigma opioid agonists. Iwamoto ET Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025 [TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087 [TBL] [Abstract][Full Text] [Related]
13. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses. James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845 [TBL] [Abstract][Full Text] [Related]
14. Response of rat globus pallidus neurons to microintophoretically applied mu and kappa opioid receptor agonists. Huffman RD; Frey JM Eur J Pharmacol; 1989 Nov; 170(3):179-91. PubMed ID: 2575994 [TBL] [Abstract][Full Text] [Related]
15. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610 [TBL] [Abstract][Full Text] [Related]
16. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility. Dray A; Metsch R Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211 [TBL] [Abstract][Full Text] [Related]
17. [Emetic and antiemetic properties of regulatory peptides]. Iasnetsov VV; Drozd IuV; Shashkov VS Biull Eksp Biol Med; 1987 May; 103(5):586-8. PubMed ID: 2439138 [TBL] [Abstract][Full Text] [Related]
18. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice. Rathbun RC; Kattau RW; Leander JD Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374 [TBL] [Abstract][Full Text] [Related]
19. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output. Craft RM; Dykstra LA J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876 [TBL] [Abstract][Full Text] [Related]